Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 31531 | 122 | 26.1 | 45% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2664 | 2947 | METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AGE RELATED PATHOLOGY | Author keyword | 1 | 50% | 1% | 1 |
| 2 | TACT EW | Address | 1 | 50% | 1% | 1 |
| 3 | HERZ KREISLAUFZENTRUM D DEN | Address | 0 | 33% | 1% | 1 |
| 4 | HUMAN CD4 CELLS | Author keyword | 0 | 33% | 1% | 1 |
| 5 | INVITROPLUS | Address | 0 | 33% | 1% | 1 |
| 6 | KLIN GEBURTSHILFE FRAUENHEILKUNDE | Address | 0 | 14% | 1% | 1 |
| 7 | LECAM 1 | Author keyword | 0 | 14% | 1% | 1 |
| 8 | ENDO REDUPLICATION | Author keyword | 0 | 11% | 1% | 1 |
| 9 | TUMOUR EVOLUTION | Author keyword | 0 | 10% | 1% | 1 |
| 10 | BIOL AGEING PROGRAM | Address | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AGE RELATED PATHOLOGY | 1 | 50% | 1% | 1 | Search AGE+RELATED+PATHOLOGY | Search AGE+RELATED+PATHOLOGY |
| 2 | HUMAN CD4 CELLS | 0 | 33% | 1% | 1 | Search HUMAN+CD4+CELLS | Search HUMAN+CD4+CELLS |
| 3 | LECAM 1 | 0 | 14% | 1% | 1 | Search LECAM+1 | Search LECAM+1 |
| 4 | ENDO REDUPLICATION | 0 | 11% | 1% | 1 | Search ENDO+REDUPLICATION | Search ENDO+REDUPLICATION |
| 5 | TUMOUR EVOLUTION | 0 | 10% | 1% | 1 | Search TUMOUR+EVOLUTION | Search TUMOUR+EVOLUTION |
| 6 | GABA A ANTOGONIST | 0 | 100% | 1% | 1 | Search GABA+A+ANTOGONIST | Search GABA+A+ANTOGONIST |
| 7 | KARYOTYPE CONTRACTION | 0 | 100% | 1% | 1 | Search KARYOTYPE+CONTRACTION | Search KARYOTYPE+CONTRACTION |
| 8 | METABOLIC RESTRICTION | 0 | 100% | 1% | 1 | Search METABOLIC+RESTRICTION | Search METABOLIC+RESTRICTION |
| 9 | SUBTYPE IDENTIFICATION | 0 | 100% | 1% | 1 | Search SUBTYPE+IDENTIFICATION | Search SUBTYPE+IDENTIFICATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VIRUS INDUCED DISEASE | 0 | 25% | 1% | 1 |
| 2 | 1 BETA CONVERTING ENZYME | 0 | 20% | 1% | 1 |
| 3 | ESTER TURBINE LUBRICANTS | 0 | 17% | 1% | 1 |
| 4 | NEUROTOXIN FORMATION | 0 | 17% | 1% | 1 |
| 5 | CAENORHABDITIS ELEGANS GENES | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| The American Aging Association honors Huber R. Warner, PhD., Retiring Associate Director, National Institute on Aging | 2005 | 0 | 8 | 25% |
| Biological threat detection via host gene expression profiling | 2003 | 6 | 31 | 10% |
| Identification of target genes of oncogenic transcription factors | 1999 | 31 | 85 | 4% |
| CLONAL ISOLATION OF HYBRIDOMAS BY MANUAL SINGLE-CELL ISOLATION | 1986 | 4 | 10 | 20% |
| Twenty years of progress in biogerontology research | 2005 | 1 | 56 | 2% |
| Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment | 2000 | 0 | 42 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TACT EW | 1 | 50% | 0.8% | 1 |
| 2 | HERZ KREISLAUFZENTRUM D DEN | 0 | 33% | 0.8% | 1 |
| 3 | INVITROPLUS | 0 | 33% | 0.8% | 1 |
| 4 | KLIN GEBURTSHILFE FRAUENHEILKUNDE | 0 | 14% | 0.8% | 1 |
| 5 | BIOL AGEING PROGRAM | 0 | 100% | 0.8% | 1 |
| 6 | EW SUPPORT MEASU ESM BRANCH | 0 | 100% | 0.8% | 1 |
| 7 | HUMAN CANC IMMUNOL UNIT | 0 | 100% | 0.8% | 1 |
| 8 | MOLEC PHARMACOL S BLDG 37 RM IC21 | 0 | 100% | 0.8% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000128935 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
| 2 | 0.0000122109 | T CELL ASSOCIATED ANTIGENS//CD8 ANTIGEN//B CELL NON HODGKIN LYMPHOMA B NHL |
| 3 | 0.0000095311 | ANTIGEN FREE MICE//X RAYS EXPOSURE//PGP 1 |
| 4 | 0.0000076862 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |
| 5 | 0.0000074762 | HEXAMETHYLENE BISACETAMIDE//MED SCI SLOAN KETTERING//HMBA |
| 6 | 0.0000058524 | BIOCHEM KITA KU//INTERLEUKIN L0//KOMPETENZZENTRUM MED TIROL |
| 7 | 0.0000048736 | REM2//RRAD//RGK |
| 8 | 0.0000047008 | CYTOTOXIC CYTOSTATIC EFFECT//TALOSIN A//6 DEOXY TALOSE |
| 9 | 0.0000046803 | P15E//CKS 17//ADV MED TREATMENTS |
| 10 | 0.0000046369 | MHC AF//IMMUNODIAG//CARBOHYDRATE COMPONENT |